Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2020 | 2 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Multiparameter immunohistochemistry analysis of HIV DNA, RNA and immune checkpoints in lymph node tissue.
J Immunol Methods. 2022 Feb;501:113198. doi: 10.1016/j.jim.2021.113198. Epub 2021 Dec 2.
J Immunol Methods. 2022.
PMID: 34863818
Free PMC article.
PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma.
Parakh S, Musafer A, Paessler S, Witkowski T, Suen CSNLW, Tutuka CSA, Carlino MS, Menzies AM, Scolyer RA, Cebon J, Dobrovic A, Long GV, Klein O, Behren A.
Parakh S, et al. Among authors: tutuka csa.
Front Immunol. 2021 Jun 9;12:672521. doi: 10.3389/fimmu.2021.672521. eCollection 2021.
Front Immunol. 2021.
PMID: 34177913
Free PMC article.
Item in Clipboard
Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes.
Prithviraj P, Anaka M, Thompson EW, Sharma R, Walkiewicz M, Tutuka CSA, Behren A, Kannourakis G, Jayachandran A.
Prithviraj P, et al. Among authors: tutuka csa.
Sci Rep. 2020 Aug 13;10(1):13779. doi: 10.1038/s41598-020-70774-9.
Sci Rep. 2020.
PMID: 32792532
Free PMC article.
Item in Clipboard
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma.
Cebon JS, Gore M, Thompson JF, Davis ID, McArthur GA, Walpole E, Smithers M, Cerundolo V, Dunbar PR, MacGregor D, Fisher C, Millward M, Nathan P, Findlay MPN, Hersey P, Evans TRJ, Ottensmeier CH, Marsden J, Dalgleish AG, Corrie PG, Maria M, Brimble M, Williams G, Winkler S, Jackson HM, Endo-Munoz L, Tutuka CSA, Venhaus R, Old LJ, Haack D, Maraskovsky E, Behren A, Chen W.
Cebon JS, et al. Among authors: tutuka csa.
J Immunother Cancer. 2020 Apr;8(1):e000410. doi: 10.1136/jitc-2019-000410.
J Immunother Cancer. 2020.
PMID: 32317292
Free PMC article.
Clinical Trial.
Item in Clipboard
PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation.
Tutuka CSA, Andrews MC, Mariadason JM, Ioannidis P, Hudson C, Cebon J, Behren A.
Tutuka CSA, et al.
Mol Cancer. 2017 Jun 28;16(1):112. doi: 10.1186/s12943-017-0684-x.
Mol Cancer. 2017.
PMID: 28659148
Free PMC article.
Item in Clipboard
Cite
Cite